Health TrialsbyHealthPanel

Effects of Kinesiotaping in Osteoarthritis

ConditionOsteoarthitis
Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age40-60
SponsorNazli Cigercioglu

About this trial

Knee osteoarthritis will be recognized as a leading cause of pain and functional disability, and conventional physiotherapy will remain a cornerstone of its management. Kinesiotaping will be widely used as an adjunct intervention; however, its additional benefit beyond standard rehabilitation programs will remain unclear.

This study will aim to investigate the additional effects of kinesiotaping combined with a conventional physiotherapy and rehabilitation program on pain, functional status, and kinesiophobia in individuals with unilateral knee osteoarthritis.

A total of 60 participants with unilateral knee osteoarthritis will be included in this randomized controlled trial and will be assigned to either a conventional physiotherapy (CP) group or a kinesiotaping (KT) group. Both groups will receive a 4-week (12 sessions) physiotherapy program including ultrasound, transcutaneous electrical nerve stimulation, patellofemoral mobilization, and exercise. Kinesiotaping will be applied every 3 days in the KT group. Outcome measures will include pain (VAS), kinesiophobia (TSK, FABQ), functional performance (30-s sit-to-stand, stair climb test), dynamic balance (functional reach), and WOMAC.

Eligibility criteria

This trial accepts healthy volunteers

Qualifiers

Diagnosis of unilateral grade 2 knee osteoarthritis,

Age between 40 and 65 years,

Ability to understand and comply with assessments and interventions,

Independent ambulation without assistive devices,

Disqualifiers

History of lower extremity surgery or trauma,

Presence of neurological or orthopedic conditions affecting gait or physical function,

Allergic reaction to kinesiotape,

Inability to walk independently.

Trial design

Design model

Sequential

Treatments tested in this trial

  • Kinesiotaping

    Other intervention

    Kinesiotaping

Treatment groups

60 Participants
are divided into 1 treatment group
Group A: KinesiotapingExperimental treatment 1 intervention

Trial outcomes

Primary outcomes

1

Kinesiophobia

Kinesiophobia will evaluated using the Tampa Scale of Kinesiophobia (TSK) and the Fear-Avoidance Beliefs Questionnaire (FABQ). The TSK is a 17-item questionnaire scored on a 4-point Likert scale (1 = strongly disagree to 4 = strongly agree), with total scores ranging from 17 to 68, where higher scores indicate greater fear of movement. The FABQ assesses fear-avoidance beliefs related to physical activity and has been widely used in musculoskeletal disorders.

Time frame
4 weeks

Secondary outcomes

1

Pain intensity

Pain intensity will be assessed using the Visual Analog Scale (VAS), a 10-cm horizontal line ranging from "no pain" (0) to "worst imaginable pain" . Participants will be asked to indicate the intensity of their knee pain during activity, and the marked distance will be measured in centimeters

Time frame
4 weeks
2

Functional status

Functional status will be assessed using performance-based tests. The 30-Second Sit-to-Stand Test will be used to evaluate lower extremity muscle strength and endurance. Participants will be instructed to stand up and sit down as many times as possible within 30 seconds, and the total number of repetitions will be recorded .

Time frame
4 weeks
3

Functional mobility

The 12-Step Stair Climb Test will be used to assess functional mobility and lower limb performance. Participants will be asked to ascend and descend a 12-step staircase as quickly and safely as possible, and the total time taken to complete the task will be recorded in seconds .

Time frame
4 weeks
4

Dynamic balance

Dynamic balance will be evaluated using the Functional Reach Test. Participants will be instructed to stand upright and reach forward as far as possible without losing balance or taking a step. The maximum distance reached will be measured in centimeters .

Time frame
4 weeks

Other outcomes

Locations

This trial has no locations.

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

Nazli Cigercioglu

Lead sponsor

Hacettepe University

Sponsor institution

Source ClinicalTrials.gov

This trial is not recruiting at the moment. You can still explore other options: